Modalis Therapeutics Balance Sheet Health
Financial Health criteria checks 5/6
Modalis Therapeutics has a total shareholder equity of ¥2.5B and total debt of ¥210.0M, which brings its debt-to-equity ratio to 8.4%. Its total assets and total liabilities are ¥2.8B and ¥298.8M respectively.
Key information
8.4%
Debt to equity ratio
JP¥210.00m
Debt
| Interest coverage ratio | n/a |
| Cash | JP¥2.70b |
| Equity | JP¥2.51b |
| Total liabilities | JP¥298.79m |
| Total assets | JP¥2.81b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 4883's short term assets (¥2.7B) exceed its short term liabilities (¥62.5M).
Long Term Liabilities: 4883's short term assets (¥2.7B) exceed its long term liabilities (¥236.3M).
Debt to Equity History and Analysis
Debt Level: 4883 has more cash than its total debt.
Reducing Debt: 4883's debt to equity ratio has increased from 0% to 8.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 4883 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 4883 has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 34.1% each year.